Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Penn-Nicholson

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
USING SPUTUM AND TONGUE SWAB SPECIMENS FOR IN-HOME POINT-OF-CARE TARGETED UNIVERSAL TESTING FOR TB OF HOUSEHOLD CONTACTS: AN ACCEPTABILITY AND FEASIBILITY ANALYSISCharl Bezuidenhout, Lawrence Long, Brooke Nichols, et al.
The European Respiratory Journal|January 22, 2021
Framework for the evaluation of new tests for tuberculosis infectionYohhei Hamada, Saskia den Boon, Daniela Maria Cirillo, et al.
Research Square|August 16, 2024
Diagnostic accuracy of LiquidArray MTB-XDR VER1.0 for the detection of <i>Mycobacterium tuberculosis</i> complex, fluoroquinolone, amikacin, ethambutol, and linezolid susceptibilityErick Auma, Rencia Alberts, Brigitta Derendinger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2024
Diagnostic accuracy of LiquidArray MTB-XDR VER1.0 for the detection of Mycobacterium tuberculosis complex, fluoroquinolone, amikacin, ethambutol, and linezolid susceptibilityErick Auma, Rencia Alberts, Brigitta Derendinger, et al.
BMJ Global Health|August 21, 2025
Using sputum and tongue swab specimens for in-home point-of-care targeted universal testing for tuberculosis of household contacts: an acceptability and feasibility analysisCharl Bezuidenhout, Lawrence Long, Brooke Nichols, et al.
Research Square|September 24, 2024
Diagnostic accuracy of Truenat MTB Plus, Truenat MTB Ultima and Xpert MTB/RIF Ultra for the diagnosis of pulmonary TB in an HIV-endemic settingShima M Abdulgader, Arthur M Chiwaya, Byron W P Reeve, et al.
Ebiomedicine|February 20, 2022
The effect of host factors on discriminatory performance of a transcriptomic signature of tuberculosis riskHumphrey Mulenga, Andrew Fiore-Gartland, Simon C Mendelsohn, et al.
Tuberculosis (Edinburgh, Scotland)|March 11, 2018
Diagnostic performance of an optimized transcriptomic signature of risk of tuberculosis in cryopreserved peripheral blood mononuclear cellsFatoumatta Darboe, Stanley Kimbung Mbandi, Ethan G Thompson, et al.
Research Square|April 10, 2026
Accuracy and clinical utility of near-point-of-care blood tests for predicting incident tuberculosis in exposed contacts in high burden settings: a multi-country observational cohort studyShima Abdulgader, Arthur Chiwaya, Marc Banuls, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 20, 2025
Diagnostic accuracy of Truenat MTB Ultima on sputum for pulmonary tuberculosis diagnosis in an HIV-endemic settingShima M Abdulgader, Arthur M Chiwaya, Welile V Nwamba, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
USING SPUTUM AND TONGUE SWAB SPECIMENS FOR IN-HOME POINT-OF-CARE TARGETED UNIVERSAL TESTING FOR TB OF HOUSEHOLD CONTACTS: AN ACCEPTABILITY AND FEASIBILITY ANALYSISCharl Bezuidenhout, Lawrence Long, Brooke Nichols, et al.
The European Respiratory Journal|January 22, 2021
Framework for the evaluation of new tests for tuberculosis infectionYohhei Hamada, Saskia den Boon, Daniela Maria Cirillo, et al.
Research Square|August 16, 2024
Diagnostic accuracy of LiquidArray MTB-XDR VER1.0 for the detection of <i>Mycobacterium tuberculosis</i> complex, fluoroquinolone, amikacin, ethambutol, and linezolid susceptibilityErick Auma, Rencia Alberts, Brigitta Derendinger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2024
Diagnostic accuracy of LiquidArray MTB-XDR VER1.0 for the detection of Mycobacterium tuberculosis complex, fluoroquinolone, amikacin, ethambutol, and linezolid susceptibilityErick Auma, Rencia Alberts, Brigitta Derendinger, et al.
BMJ Global Health|August 21, 2025
Using sputum and tongue swab specimens for in-home point-of-care targeted universal testing for tuberculosis of household contacts: an acceptability and feasibility analysisCharl Bezuidenhout, Lawrence Long, Brooke Nichols, et al.
Research Square|September 24, 2024
Diagnostic accuracy of Truenat MTB Plus, Truenat MTB Ultima and Xpert MTB/RIF Ultra for the diagnosis of pulmonary TB in an HIV-endemic settingShima M Abdulgader, Arthur M Chiwaya, Byron W P Reeve, et al.
Ebiomedicine|February 20, 2022
The effect of host factors on discriminatory performance of a transcriptomic signature of tuberculosis riskHumphrey Mulenga, Andrew Fiore-Gartland, Simon C Mendelsohn, et al.
Tuberculosis (Edinburgh, Scotland)|March 11, 2018
Diagnostic performance of an optimized transcriptomic signature of risk of tuberculosis in cryopreserved peripheral blood mononuclear cellsFatoumatta Darboe, Stanley Kimbung Mbandi, Ethan G Thompson, et al.
Research Square|April 10, 2026
Accuracy and clinical utility of near-point-of-care blood tests for predicting incident tuberculosis in exposed contacts in high burden settings: a multi-country observational cohort studyShima Abdulgader, Arthur Chiwaya, Marc Banuls, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 20, 2025
Diagnostic accuracy of Truenat MTB Ultima on sputum for pulmonary tuberculosis diagnosis in an HIV-endemic settingShima M Abdulgader, Arthur M Chiwaya, Welile V Nwamba, et al.
Pageof 10